Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3350 of 3546 entries
View as:

A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

Phase: N/A Priority: Normal
NCT ID: NCT01266980 Org: User:
Start: 11/18/10 End: 03/22/11 Due: 03/22/12

Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01047397 Org: User:
Start: 03/31/10 End: 02/28/11 Due: 02/28/12

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00422604 Org: User:
Start: 10/31/06 End: 05/31/07 Due: 05/31/08

A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06748053 Org: User:
Start: 02/10/25 End: 01/14/27 Due: 01/14/28

A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT00811733 Org: User:
Start: 03/01/09 End: 02/01/14 Due: 02/01/15

Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses

Phase: N/A Priority: Normal
NCT ID: NCT01894386 Org: User:
Start: 07/15/13 End: 09/26/13 Due: 09/26/14

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01343043 Org: User:
Start: 09/27/12 End: 06/18/19 Due: 06/18/20

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00661557 Org: User:
Start: 05/19/08 End: 12/19/08 Due: 12/19/09

Trends Over Time (1990-2010) of Diarrhoea-related Incidence, Hospitalizations and Deaths in Children of Panama

Phase: N/A Priority: Normal
NCT ID: NCT01171144 Org: User:
Start: 01/31/09 End: 09/30/11 Due: 09/30/12

Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants

Phase: N/A Priority: Normal
NCT ID: NCT01262872 Org: User:
Start: 02/09/11 End: 03/18/13 Due: 03/18/14

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00197171 Org: User:
Start: 09/30/03 End: 12/31/03 Due: 12/31/04

SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World

Phase: N/A Priority: Normal
NCT ID: NCT01390935 Org: User:
Start: 03/31/11 End: 05/31/12 Due: 05/31/13

Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00621322 Org: User:
Start: 04/03/08 End: 04/03/09 Due: 04/03/10

BENLYSTA® Special Drug Use Investigation

Phase: N/A Priority: Normal
NCT ID: NCT03370263 Org: User:
Start: 01/15/18 End: 06/26/25 Due: 06/26/26

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Phase: N/A Priority: Normal
NCT ID: NCT03511105 Org: User:
Start: 06/25/18 End: 12/18/18 Due: 12/18/19

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00838903 Org: User:
Start: 02/28/09 End: 04/30/13 Due: 04/30/14

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT03045861 Org: User:
Start: 03/17/17 End: 04/23/18 Due: 04/23/19

Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug

Phase: N/A Priority: Normal
NCT ID: NCT00043901 Org: User:
Start: 12/01/00 End: 03/01/05 Due: 03/01/06

Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01480622 Org: User:
Start: 12/05/11 End: 12/30/11 Due: 12/30/12

Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04640311 Org: User:
Start: 12/18/20 End: 05/18/21 Due: 05/18/22

CV Events in Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01366599 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00289783 Org: User:
Start: 02/22/06 End: 02/26/08 Due: 02/26/09

A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.

Phase: N/A Priority: Normal
NCT ID: NCT00388596 Org: User:
Start: 10/31/06 End: - Due: -

Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00549146 Org: User:
Start: 11/30/03 End: 04/30/06 Due: 04/30/07

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05999799 Org: User:
Start: 11/16/23 End: 07/24/25 Due: 07/24/26